Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Phys Med Rehabil Clin N Am. 2012 Aug;23(3):495–563. doi: 10.1016/j.pmr.2012.06.011

Table 5.

Characteristics of Common Autosomal Dominant Limb Girdle Muscular Dystrophies (AD-LGMD)

LGMD 1A LGMD 1B LGMD 1C
U.S. Prevalence 4,200 2,850 675
Inheritance AD AD AD
Gene Location 5q31 1q11-q21 3p25
Protein Myotilin Lamin A/C Caveolin-3
Onset
  • Variable

  • Third to seventh decade

  • Anticipation: age of onset decreases in succeeding generations

  • < 20 years

  • 5 years to adulthood

Severity & Course
  • Slow progression

  • Slow progression

  • Upper limbs involved by third or fourth decade

  • Moderate severity and progression

  • Adults with Gower’s maneuver

Weakness
  • Legs and arms

  • Symmetric

  • Proximal at onset

  • Early foot drop

  • Distal with disease progression

  • Wrist and finger extensors + deltoid

  • Dysarthria (30%)

  • Facial (17%)

  • Neck extensors in some patients

  • Lower limb

  • Symmetric

  • Proximal

  • Variant: Quadriceps weakness with Arg377His mutation

  • Proximal

Ambulation Status
  • Late loss of ambulation (> 10 years after onset)

  • Mild: Adults continue to ambulate with Gower’s maneuver

Cardiac
  • Cardiomyopathy 50%

  • Onset 6th or 7th decade

  • Cardiomyopathy 62%

  • AV conduction block

No Cardiomyopathy
Respiratory
  • Mild restrictive lung disease

  • Mild restrictive lung disease

  • Mild restrictive lung disease

Muscle size
  • Hypertrophy of calf

Musculo-skeletal
  • Contractures: ankles (30%)

  • No contractures

  • Cramps after exercise

CNS
  • No intellectual defect reported

  • No intellectual defect reported

  • No intellectual defect reported

Muscle pathology
  • Myopathic

  • Variable fiber size

  • Fiber degeneration and regeneration

  • Rimmed vacuoles

  • Normal levels of Myotilin or increased immunostaining

  • Reduced laminin-gamma1

  • Type I predominance with increasing weakness

  • Normal Dystrophin & Sarcoglycan

  • Laminin A subcellular localization:

    • Normal: Nucleus; Co-localizes with Emerin

    • Mutated: May aggregate in nucleus & be present in cytoplasm

  • Myopathic

  • Reduced caveolin-3 staining: No 21-kD band on Western blot

Blood chemistry
  • CK: 1 to 15 times normal; commonly twice normal

  • CK: Normal to mildly elevated

  • CK: 4 to 25 times normal